 "vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab")
India has included Gilead’s remdesivir in its clinical protocol to treat Covid-19 patients and also advised the use of dexamethasone as an alternative to another steroid being used for managing moderate to severe cases.
The Ministry of Health and Family Welfare (MoHFW) on Saturday released the updated clinical management protocol for managing Covid-19 cases. The protocol included the use of dexamethasone, an inexpensive and widely used steroid, as a substitute for methylprednisolone. The ministry said the change had been made after considering the latest available evidence and expert consultation.
Dexamethasone is a corticosteroid drug used in a wide range of
